Pune, India -- (SBWire) -- 02/19/2018 --The Global Active Pharmaceutical Ingredients Market is expecting a swift growth in coming future. Increasing prevalence of different chronic diseases, rising number of cancer patients and increasing governmental support for the development of the new drugs has driven the growth of the market. While high cost of R&D and strict regulatory requirement has restrain the growth of the market.
Regional Analysis
The Global Active Pharmaceutical Ingredients Market is segmented into America, Europe, Asia Pacific and Middle East and Africa. America commands the largest market, majorly due to increasing prevalence of different chronic diseases and rise in the number of cancer patients. According to national cancer institute, in 2016 723,350 new cancer cases was registered in America. North America contributes a major share in America market. Besides increasing prevalence of cancer, well developed healthcare sector, increasing healthcare expenditure and adoption of biologic drugs by peoples has contributed in the growth of the market in this region.
Europe accounts the second largest market for active pharmaceutical ingredients which is followed by Asia Pacific. Asia Pacific region is expecting a fastest growth for active pharmaceutical ingredients market during forecast period from 2017-2023. Rapidly growing economies and rising awareness about the people is the major factor for the growth of the market. The majority of NSAIDs and antibiotic drugs are manufacture in India and China. Lower labor cost and availability of abundant raw materials in these countries are the key factor for the growth of API market in India and China. In addition to this, regulatory support and government encouragement to establish API manufacturing plants by favorable taxes are helping the active pharmaceutical ingredients market in Asia Pacific.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1385 .
The major key players for the global active pharmaceutical ingredients market are Teva Pharmaceutical Industries (Israel), Cipla (India), Dr. Reddy's Laboratories (India), Novartis International AG (Switzerland), Sanofi (France), Pfizer, Inc. (US), Eli Lilly and Company (US), Aurobindo Pharma (US), Sun Pharmaceutical Industries (India), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (US), GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), AbbVie Inc. (US).
Regional Analysis:
On regional basis, America dominates the market for active pharmaceutical ingredients. Increasing R&D expenditure, increasing incidence of chronic diseases and technological advancements in drug manufacturing are key factor for the growth of the market in this region. Europe accounts second largest market which is followed by Asia Pacific. Asia Pacific is the fastest growing region owing to the availability affordable work force and increasing API manufacturing units in these countries.
Major TOC for Active Pharmaceutical Ingredients Market:
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1385 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Active Pharmaceutical Ingredients Market 2018 : Unleashing the Power of Pharmaceutical Industry : Forecasts Till 2023
The Active Pharmaceutical Ingredients Market analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Active Pharmaceutical Ingredients market.